A Systematic Review and Meta-analysis of Clinical, Respiratory, and Biochemical Risk Factors for Acute Exacerbation of idiopathic Pulmonary Fibrosis

Medicine and Dentistry

• Systematic Review 100%
• Meta-Analysis 100%
• Idiopathic Pulmonary Fibrosis 100%
• Health Care Cost 33%
• Biological Marker 33%
• Cross Sectional Study 33%
• Prospective Study 33%
• Leukocyte 33%
• Cell Count 33%
• Lung Injury 33%
• Interleukin 8 33%
• Checklist 33%
• Critical Appraisal 33%
• Forced Vital Capacity 33%
• C Reactive Protein 33%
• Six Minute Walk Test 33%
• Respiratory Physiology 33%
• Interleukin 1 33%
• Synapsin I 33%
• Lactate Dehydrogenase 33%
• Vital Capacity 33%
• Total Lung Capacity 33%
• Diseases 33%
• Interleukin 6 33%
• Carbon Monoxide 33%
• Lung Diffusion Capacity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Fibrosing Alveolitis 100%
• Carbon Monoxide 33%
• Prospective Study 33%
• Diseases 33%
• Biological Marker 33%
• Inflammation 33%
• Cross-Sectional Study 33%
• C Reactive Protein 33%
• Interleukin 6 33%
• Interleukin 8 33%
• Lung Injury 33%
• Lactate Dehydrogenase 33%
• Interleukin 1 33%
• Synapsin I 33%
• High Mobility Group B1 Protein 33%

Biochemistry, Genetics and Molecular Biology

• Vital Capacity 100%
• High-Mobility Group 100%
• Lung Diffusion Capacity 100%
• Surfactant Protein D 100%